Beta
Trial Radar KI
Die klinische Studie NCT07488585 (THYMAL 01) für Schilddrüsenknoten, Thyroid Abnormalities ist noch nicht rekrutierend. In der Kartenansicht des Klinische Studien Radar und den KI-Entdeckungstools finden Sie alle Details. Oder stellen Sie hier Ihre Fragen.
Eine Studie entspricht den Filterkriterien
Kartenansicht

This Study Tests a New Sound Blade Ultrasound for Thyroid Scans. It Compares Its Images With Regular Hospital Ultrasounds to See Which is Clearer. The Images Will Help Build Future AI Tools to Improve Care. (THYMAL 01) 30

Noch nicht rekrutierend
Die Details der klinischen Studie sind hauptsächlich auf Englisch verfügbar. Trial Radar KI kann jedoch helfen! Klicken Sie einfach auf 'Studie erklären', um die Informationen zur Studie in der ausgewählten Sprache anzuzeigen und zu besprechen.
Die klinische Studie NCT07488585 (THYMAL 01) ist eine interventionsstudie zur Untersuchung von Schilddrüsenknoten, Thyroid Abnormalities und hat den Status noch nicht rekrutierend. Der Start ist für 31. Mai 2026 geplant, bis 30 Teilnehmer aufgenommen werden. Durchgeführt von Sound Blade Medical Inc. wird der Abschluss für 1. September 2027 erwartet. Die Daten von ClinicalTrials.gov wurden zuletzt am 23. März 2026 aktualisiert.
Kurzbeschreibung
This study is testing a new type of ultrasound made just for looking at the thyroid, a small gland in the neck. During one clinic visit, people will have two safe and painless scans: the regular ultrasound they would normally get, and a second scan using the research device. Both scans use a probe on the skin with gel-there are no needles, no radiation, and no changes to their medical care. The goal is to see if the ...Mehr anzeigen
Ausführliche Beschreibung
Our purpose-built thyroid US platform, integrated with state-of-the-art machine-learning algorithms, will achieve accurate detection and delineation of thyroid nodules and neighboring critical structures, and will produce a trackable three-dimensional nodule model capable of guiding minimally invasive ablation while providing real-time volumetric quantification of treatment progress and residual disease.

STUDY DESIG...

Mehr anzeigen
Offizieller Titel

A Novel Ultrasound Probe for Thyroid Imaging and Machine Learning: A Pilot Study

Erkrankungen
SchilddrüsenknotenThyroid Abnormalities
Weitere Studien-IDs
  • THYMAL 01
NCT-Nummer
Studienbeginn (tatsächlich)
2026-05-31
Zuletzt aktualisiert
2026-03-23
Studienende (vorauss.)
2027-09
Geplante Rekrutierung
30
Studientyp
Interventionsstudie
PHASE
Nicht zutreffend
Status
Noch nicht rekrutierend
Stichwörter
Thyroid Nodule
Primäres Ziel
Diagnostisch
Zuteilungsmethode
Nicht zutreffend
Interventionsmodell
Einarmige Studie
Verblindung
Keine (offene Studie)
Studienarme/Interventionen
Teilnehmergruppe/StudienarmIntervention/Behandlung
ExperimentellParticipants who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound
Patients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound after signing consent will undergo a second ultrasound using the Sound Blade Ultrasound. It will be done at the same visit, right after the SOC ultrasound is complete.
Thyroid ultrasound
Patients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound after signing consent will undergo a second ultrasound using the Sound Blade Ultrasound. It will be done at the same visit, right after the SOC ultrasound is complete.
Hauptergebnismessungen
ErgebnismessungBeschreibung der MessungZeitrahmen
Part A: Prospective Thyroid Imaging Study Objective: Visualization and Image Quality Assessment of Key Neck Structures Using Ultrasound Visibility Scale and Radiologist Comparison Form
1 Visibility Scale (Primary Component) Independent, blinded radiologists will rate the visibility of each structure using a 3-point scale: 0 = Not Visible (structure cannot be identified) 1. = Partially Visible (structure identifiable but with limited definition) 2. = Fully Visible (structure clearly identified with complete anatomic definition) Scores from each reviewer will be averaged for analysis. 2. Radiologist Comparative Image Quality Form (Secondary of Primary Outcome) Radiologists will complete a structured comparison form evaluating: Size (agreement between devices; measured in mm) Margins (sharp, indistinct, irregular) Edge Definition (well-defined vs. poorly defined) Overall Visibility (device-to-device comparison: better, worse, equivalent) These assessments will be recorded for each thyroid nodule and relevant neck structure. The primary endpoint is the difference in mean visibility scores and qualitative image quality ratings between the investigational and SOC ultrasound
This will take place at month 3 to end of month 7 of study.
Part B: Machine Learning Model Development Objective Develop and internally evaluate a machine-learning model that identifies and segments thyroid nodules and predefined neck structures (carotid, jugular, vagus nerve, trachea, thyroid nodule) on image
Outcome Measure 1: Segmentation Accuracy Performance of the machine-learning model in segmenting thyroid nodules and neck structures (carotid artery, internal jugular vein, vagus nerve, trachea). Accuracy will be evaluated using overlap-based metrics, including the Dice Similarity Coefficient and Intersection-over-Union (IoU). These unitless measures quantify agreement between the model-generated segmentation and expert-annotated reference masks. Outcome Measure 2: Visibility and Detection Performance Performance of the model in identifying the presence or absence of thyroid nodules and key neck structures on ultrasound images. Detection quality will be assessed using standard classification metrics, including sensitivity, specificity, positive predictive value, negative predictive value, and area under the ROC curve (AUC). These metrics quantify diagnostic accuracy. Outcome Measure 3: 3-D Reconstruction and Focus-Tracking Feasibility Feasibility of generating consistent 3-D thyroid
At month 4 until then end of the study, month 12.
Teilnahme-Assistent
Eignungskriterien

Zugelassene Altersgruppen
Erwachsene, Ältere Erwachsene
Mindestalter
18 Years
Zugelassene Geschlechter
Alle
  • Participants must be ≥ 18 years of age
  • Competent to sign informed consent
  • Known thyroid nodule demonstrated on a prior thyroid US and is undergoing active surveillance of the nodule with serial USs

  • Unable to lay flat for 15 minutes
  • Active neck wounds, dressings, or skin conditions that would interfere with neck US (e.g., preclude transducer placement)
  • Cervical spine or back disease that would prevent neck extension and would hinder the ability to obtain accurate thyroid US images
  • Previous thyroid surgeries, radiation of face and neck
  • Known inflammatory thyroid diseases or thyroiditis (e.g., Graves, Hashimoto)
Sound Blade Medical Inc. logoSound Blade Medical Inc.
Zentrale Studienkontakte
Kontakt: Deborah Wright, Project Manager, RN, 902-225-6835, [email protected]
Kontakt: Richard Balys, MD, MD, 902-223-8032, [email protected]
Keine Standortdaten vorhanden